ABOUT
Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
Uniquely positioned as the most comprehensive biopharma forum, the 7th Exosome-Based Therapeutic Development Summit brings together exosome giants and new players in the field, showcasing emerging applications from CNS disorders to cancer, new trends in characterization and analytical development, purification and isolation technologies through to manufacturing at clinical-grade scale and key considerations for regulatory IND and commercial filing.
Don’t miss this opportunity to engage with the leading players making the biggest leaps in exosome research towards commercial markets and gain first-hand insights and takeaways to get up to speed and advance your pipelines.
Key Clinical Updates From
Key Benefits of Attending
Achieve the scale and manufacturing excellence of your exosome products with GMP compliance and batch-to-batch consistency for commercial viability with insights from EXO Biologics, EverZom & NurExone Biologic
Advance your pipelines toward the clinic with fresh data and experience from leading exosome & EV developers on the path towards the first therapeutic approval, with insights from Direct Biologics, Rion, Aegle Therapeutics & Aruna Bio
Harness translational strategies & therapeutic innovations with relevant translational model case-studies to reinvigorate your pipeline with insights from EV Therapeutics, Diadem Biotherapeutics & Capricor Therapeutics
Establish robust and standardized analytical and characterization methods to unlock size, surface markers, andexosome isolation techniques with insights from VesiCURE Therapeutics, Loyola University Chicago & Clemson University
Leverage exosomes & EVs as the delivery vehicle of choice for a variety of payloads with improved tropism, targeted delivery, and immunogenicity with insights from ShiftBio & AGS Therapeutics
Don't Just Take Our Word For It...
“This Exosome-Based Therapeutic Development Summit is crucial for connecting with industry leaders, sharing ideas, and developing improved therapeutics”
Inkyu Lee, R&D Senior Researcher & Business Development Senior Manager, ShiftBio
“This meeting is a chance to exchange ideas at the leading edge of exosome science. I value the opportunity to share insights from the lab, learn from others, challenge my assumptions and spark collaborations to drive real breakthroughs”
Mickey Pentecost, Chief Scientific Officer, Diadem Biotherapeutics